{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:09:17Z","timestamp":1781647757519,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005170","name":"Ohio Department of Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ajoc.2020.100962","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:23:35Z","timestamp":1602145415000},"page":"100962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4581-8204","authenticated-orcid":false,"given":"Rebecca I.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan D.","family":"Deaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-7238","authenticated-orcid":false,"given":"Careen Y.","family":"Lowder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2020.100962_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/003591576505800106","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc Roy Soc Med"},{"key":"10.1016\/j.ajoc.2020.100962_bib2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM198312083092306","article-title":"Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so-benign virus","volume":"309","author":"Weller","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2020.100962_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2990.2011.01167.x","article-title":"The neurobiology of varicella zoster virus infection","volume":"37","author":"Gilden","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"10.1016\/j.ajoc.2020.100962_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1060028018758431","article-title":"Shingrix: the new adjuvanted recombinant herpes zoster vaccine","volume":"52","author":"James","year":"2018","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.ajoc.2020.100962_bib5","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in Varicella-Zoster Virus (VZV) \u2013specific cell-mediated immunity with increasing age and boosting with a high-dose VZV Vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajoc.2020.100962_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200003023420906","article-title":"Neurologic complications of the reactivation of varicella-zoster virus","volume":"342","author":"Gilden","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2020.100962_bib7","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Prim"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100962_bib8","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1080\/21645515.2017.1317410","article-title":"A critical appraisal of \u2018Shingrix\u2019, a novel herpes zoster subunit vaccine (HZ\/Su or GSK1437173A) for varicella zoster virus","volume":"13","author":"Bharucha","year":"2017","journal-title":"Hum Vaccines Immunother"},{"issue":"5","key":"10.1016\/j.ajoc.2020.100962_bib9","first-page":"604","article-title":"Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trails, 1987 to 1989","volume":"87","author":"White","year":"1991","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajoc.2020.100962_bib10","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1080\/21645515.2018.1456598","article-title":"Post-licensure safety surveillance of zoster vaccine live (Zostavax) in the United States, vaccine adverse event reporting System (VAERS), 2006-2015","volume":"14","author":"Miller","year":"2018","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.ajoc.2020.100962_bib11","author":"Morgan Healthcare Conference"},{"key":"10.1016\/j.ajoc.2020.100962_bib12","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijms20040954","article-title":"Recombinant glycoprotein E of varicella zoster virus contains glycan-peptide motifs that modulate B cell epitopes into discrete immunological signatures","volume":"20","author":"Norden","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100962_bib13","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1080\/21645515.2016.1154247","article-title":"Comparative preclinical evaluation of AS01 versus other adjuvant systems in a candidate herpes zoster glycoprotein E subunit vaccine","volume":"12","author":"Fochesato","year":"2016","journal-title":"Hum Vaccines Immunother"},{"issue":"2","key":"10.1016\/j.ajoc.2020.100962_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ajoc.2020.100962_bib15","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S1473-3099(19)30163-X","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised clinical trial and post-hoc efficacy analysis","volume":"19","author":"Dagnew","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.ajoc.2020.100962_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0002-9394(99)00059-8","article-title":"Uveitis associated with varicella virus vaccine","volume":"127","author":"Esmaeli-Gutstein","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100962_bib17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archophthalmol.2010.142","article-title":"Exacerbation of zoster interstitial keratitis after zoster vaccination in an adult","volume":"128","author":"Khalifa","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2020.100962_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/archophthalmol.2008.569","article-title":"Interstitial keratitis following varicella vaccination","volume":"127","author":"Nagpal","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2020.100962_bib19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archophthalmol.2011.320","article-title":"Acute retinal necrosis after herpes zoster vaccination","volume":"129","author":"Charkoudian","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajoc.2020.100962_bib20","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/archophthalmol.2012.2255","article-title":"Retinal necrosis following varicella-zoster vaccination","volume":"130","author":"Gonzales","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2020.100962_bib21","first-page":"1","article-title":"Acute retinal necrosis and contralateral cutaneous eruption after the shingles vaccine","author":"Ali","year":"2018","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajoc.2020.100962_bib22","first-page":"1","article-title":"Acute retinal necrosis associated with herpes zoster vaccination","author":"Menghini","year":"2018","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajoc.2020.100962_bib23","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/cid\/cix683","article-title":"Acute retinal necrosis caused by the zoster vaccine virus","volume":"65","author":"Heath","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.ajoc.2020.100962_bib24","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ajoc.2020.100962_bib25","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100962_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.15585\/mmwr.mm6804a4","article-title":"Postlicensure safety surveillance of recombinant zoster vaccine (Shingrix) \u2013 United States, October 2017 \u2013 june 2018","volume":"68","author":"Hesse","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100962_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization Practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajoc.2020.100962_bib28","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3389\/fimmu.2018.01632","article-title":"Herpes zoster and immunogenicity and safety of zoster vaccines in transplant patients: a narrative review of the literature","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620302772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620302772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:58:23Z","timestamp":1762527503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993620302772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"alternative-id":["S2451993620302772"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100962","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100962"}}